date:Feb 04, 2013
id Dennis Savaiano, Ph.D., professor of Nutrition Science at Purdue University and chair of Ritter Pharmaceuticals' Medical Advisors, whose investigational drug, RP-G28 is in mid stage clinical research for treating lactose intolerance. Patients who avoid milk have lower calcium intakes and typically lower bone density -- a strong risk factor for osteoporosis. Dairy avoidance is not the appropriate method of managing these patients, he added.